New York-based NYU Langone Medical Center's Perlmutter Cancer Center announced Monday that it will create the Pancreatic Cancer Center dedicated solely to research and treatment of the disease that is expected to be the second leading cause of cancer death by 2020.
Diane M. Simeone, MD, will be director of the new center. Dr. Simeone joined the staff at NYU Langone this past March after 22 years at the University of Michigan's Comprehensive Cancer Center.
"In the past, pancreatic cancer took a back seat to the investigation of other forms of cancer," Dr. Simeone said. "But the increasing number of cases has changed that. We will advance the most promising laboratory findings to the clinic in the shortest possible time, improve clinical trial design and efficiency, facilitate data sharing and capitalize fully on technologic advances that will one day lead us to an early detection test for pancreatic cancer."
More Articles on Facilities Management:
Optum's MedExpress to open urgent care center 1 mile from Mayo Clinic
Dignity Health system opens 'neighborhood hospital' in Las Vegas with Emerus
6 hospitals planning facility upgrades, expansions